TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swedish Pharma Compliance AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
547
|
757
|
789 |
Financial expenses |
1
|
0
|
1 |
Earnings before taxes |
130
|
479
|
477 |
EBITDA |
129
|
479
|
478 |
Total assets |
1,899
|
1,838
|
1,710 |
Current assets |
846
|
1,081
|
929 |
Current liabilities |
131
|
96
|
121 |
Equity capital |
1,769
|
1,741
|
1,589 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.2%
|
94.7%
|
92.9% |
Turnover per employee |
547
|
757
|
789 |
Profit as a percentage of turnover |
23.8%
|
63.3%
|
60.5% |
Return on assets (ROA) |
6.9%
|
26.1%
|
28.0% |
Current ratio |
645.8%
|
1126.0%
|
767.8% |
Return on equity (ROE) |
7.3%
|
27.5%
|
30.0% |
Change turnover |
-263
|
-9
|
-160 |
Change turnover % |
-33%
|
-1%
|
-17% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.